Mfd. by :- Merck sharp (Fulfilled By : Magicine Pharma)
Magicine Pharma is registered with the Government Of NCT, India, Ministry Of Health in Government of Delhi, India, registration number DL-RAJ-122372 and as a wholesale distributor, department file No. 44208.
Brand Name:- Keytruda
Generic Name:- Pembrolizumab
Strength :- 100mg/4ml
Dosage Form:- Injection
Packaging Size:- 1 vial
Manufacturer:- Merck sharp
Composition:- Pembrolizumab
Indications:- Head and neck cancer, lung cancer, skin cancer, gastric cancer
Storage:- Store in a cool and dry place
Description
Keytruda injection (Pembrolizumab) is a cancer medicine that interferes with the growth and spread of cancer cells in the body. It is used with other types of medicine to cure certain types of cancers such as lung cancer, skin cancer, gastric cancer, liver cancer. This medicine is used to treat a kind of lung cancer called non-small cell lung cancer. It is an immunotherapy that works with your immune system to fight cancer. Keytruda is often given when cancer has spread to other parts of the body and cannot be treated with chemotherapy or radiation therapy. Keytruda can cause side effects in different parts of your body.
It is indicated for the treatment of patients with metastatic myeloma.
It is indicated for the treatment of small-cell lung cancer
It is indicated for the treatment of adult and pediatric patients with metastatic microsatellite instability-high(MSI-H).
Keytruda, in combination with axitinib, is indicated for the first-line treatment of patients with advanced renal cell carcinoma RCC.
It may cause some unwanted effect. Although all of these side effects may not occur, if they occur it requires immediate medical attention.
Common side effect
Blurred vision
Skin rash
Vomiting
Sore throat
Constipation
Bloating or swelling in the face, arms, legs, and feet.
Muscle cramps
Pale skin
Runny or stuffy nose
Unusual bleeding
Unusual weight gain or loss
Change in eyesight
Fever
Yellow eyes or skin
Severe or sudden headache
Diarrhea
Sweating
Drooping eyelids
Nosebleeds
Redness of eye
Indigestion
Scaly skin
Loss of appetite
Dark urine
Drowsiness
NOTE:- Immediately contact your doctor if any of these side effects occur.
Keytruda injection (Pembrolizumab) is used to treat both small cell lung cancer and non-small cell cancer. This type of lung cancer is the most common. It is approved to treat melanoma that can’t be removed surgically.
The drug is used to prevent skin cancer from coming back. It is also approved to treat certain types of bladder cancer. For this use, keytruda is given to people who have chosen not to have surgery for their cancer.
Before taking kedura talk to your doctor about your medical history. It may not be right for you in certain medical conditions.
It may cause some severe effect on your immune system
If you’ve had an allogeneic stem transplant, consult your doctor about keytruda.
Using keytruda with certain other drugs may increase the risk of death.
It is not safe for pregnant woman, as it may cause harm to the unborn baby
Breastfeeding is not recommended for women who are taking keytruda.
It may cause some allergic reaction, please consult your doctor.
Cautionary labels
May harm the immune system
Do not drive after taking this medication
Not safe for pregnant women
Do not take this medication without doctor advice
Ans. Pemrulizumab blocks the PD-1 (type of protein) receptor, preventing binding and activation of PD-L1 and PD-L2. This process results in the activation of T-cell mediated immune responses in contrast to tumor cells.
Ans. keytruda is a type of immunotherapy that works by blocking the PD-1 pathway and to help prevent cancer cells from hiding. Keytruda helps the immune system to detect and fight cancer.
Ans. common side effects are vomiting, skin rash, nausea, blurred vision, dizziness, constipation, sore throat, pale skin, muscle cramps etc.
Ans. It is available in 100mg/4ml solution in a single dose vial.
Ans. keytruda is an immunotherapy medicine that may treat certain cancers by working with your immune system. Immunotherapy is a type of cancer treatment that uses your own immune system to help detect and fight cancer.
Ans. It usually takes 30 minutes after you have it.
Ans. It is measured by a shrinking or stable tumor. During and after treatment, the patient will have a regular checkup with his or her physician.
Ans. If you have symptoms of lung problem(shortness of breath, chest pain), kidney problem and other signs of problem with other organs like:- rash, change in eyesight, severe muscle weakness.
Ans. Your doctor will give you an injection into your vein. It is given every 3 weeks. Your doctor will decide how many treatments you need.
Ans. Patients receiving keytruda are monitored with blood work and other laboratory tests to check the adverse reaction on the immune system like:- changes in kidney and thyroid function, hepatitis, colitis and pneumonitis.
Ans. This medication is not recommended for pregnant womens, because it may harm the unborn baby.
Ans It is unsafe during breastfeeding, that’s why it is not recommended for breastfeeding womens.
Ans. Contact your doctor immediately, in case you miss a dose.
Ans. It can pass into body fluids(urine, vomits). For 48 hours after taking a dose, avoid allowing your body fluid to come in contact with your hand or other surfaces.
Keytruda 100mg (Pembrolizumab) interaction
Betamethasone
Budesonide
Pembrolizumab interaction with disease
Infections
Renal dysfunction
Kidney disease
Infusion reaction
Colitis
Pneumonitis
Multiple myeloma
Diabetes
Hepatic impairment
Cortisone
Deflazacort
Dexamethasone
Hydrocortisone
Lenalidomide
Methylprednisolone
Pomalidomide
Prednisolone
Prednisone
Thalidomide
Triamcinolone
Keytruda: Drug information available at: https://go.drugbank.com/drugs/DB09037
Keytruda: Drug Uses, mechanism, and Side Effects available at: https://www.mayoclinic.org/drugs-supplements/pembrolizumab-intravenous-route/side-effects/drg-20122552 and https://www.keytruda.com/side-effects/.
Fill the Form
Talk to Executive
Get Tracking
Get Medicines Delivered
